Creoptix — a Malvern Panalytical brand

Following the acquisition by Malvern Panalytical, our Twitter account will be now integrated. Follow @newsfrom_MP to stay in touch 😊 You can also follow us on LinkedIn: linkedin.com/company/creopt…

Interested in #immunotherapy #DrugDevelopment and innovative in vitro assays? Watch this FREE #biologics masterclass to learn how to select the best assay for your drug target: bit.ly/3vMo8Mu
For similar content, follow Malvern Panalytical: x.com/newsfrom_MP

WAVEdelta is featured in a new #article:
To determine the #affinity between the plant membrane receptor protein HSL1 and the IDA/IDL peptides, as well as complex formation with the co-receptor SERK, involved the regulation of epidermal cell patterning.

lnkd.in/dY5WXX32

We're proud to announce that Creoptix was acquired by Malvern Panalytical @newsfrom_MP . Becoming part of this family is an important step in #accelerating the delivery of our vision to advance breakthrough science, faster.

Learn more: creoptix.com/about-us/news/…

Bioassay techniques tend to capture just one point in time. Label-free technology enables interaction to be monitored in real-time. Get better, more physiologically relevant insights: lnkd.in/dSjEZRBB